Other
Change in Operating Capital
West Pharmaceutical Services Change in Operating Capital increased by 2409.8% to $102.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 103000.0%, from -$100.00K to $102.90M.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2024
Last reportedQ1 2026Apr 23, 2026
How to read this metric
An increase suggests cash is being tied up in working capital, while a decrease indicates improved cash conversion efficiency.
Detailed definition
This metric represents the net impact of changes in working capital components, such as accounts receivable, inventory,...
Peer comparison
Commonly reported as 'Changes in Working Capital' in the cash flow statement across all industries.
Metric ID:
cvx_change_in_operating_capitalHistorical Data
5 periods
| Q1 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $34.60M | $100.00K | -$100.00K | $4.10M | $102.90M |
| QoQ Change | — | -99.7% | -200.0% | >999% | >999% |
| YoY Change | — | — | -100.3% | — | >999% |
Range-$100.00K – $102.90M
CAGR+197.4%
Avg YoY Growth>999%
Median YoY Growth>999%
Current Streak2 quarters growth
Change in Operating Capital at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's change in operating capital?
- West Pharmaceutical Services (WST) reported change in operating capital of $102.90M in Q1 2026.
- How has West Pharmaceutical Services's change in operating capital changed year-over-year?
- West Pharmaceutical Services's change in operating capital increased by 103000.0% year-over-year, from -$100.00K to $102.90M.
- What does change in operating capital mean?
- The net cash impact resulting from changes in current assets and current liabilities.